The blood-brain barrier and multiple sclerosis.

[1]  C. Polman,et al.  Multiple sclerosis: some possible therapeutic opportunities. , 1993, Trends in pharmacological sciences.

[2]  J. Damoiseaux,et al.  Treatment with anti‐CR3 antibodies ED7 and ED8 suppresses experimental allergic encephalomyelitis in Lewis rats , 1993, European journal of immunology.

[3]  A. Thompson,et al.  High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[4]  B. Jaffee,et al.  Therapy of chronic relapsing experimental allergic encephalomyelitis and the role of the blood-brain barrier: elucidation by the action of Brequinar sodium , 1992, Journal of Neuroimmunology.

[5]  E. Thompson,et al.  In vivo relationship of tumor necrosis factor-α to blood-brain barrier damage in patients with active multiple sclerosis , 1992, Journal of Neuroimmunology.

[6]  F. Sánchez‐Madrid,et al.  Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin , 1992, Nature.

[7]  F. Barkhof,et al.  A correlative triad of gadolinium‐DTPA MRI, EDSS, and CSF‐MBP in relapsing multiple sclerosis patients treated with high‐dose intravenous methylprednisolone , 1992, Neurology.

[8]  A. Compston.  Neurology Neurosurgery & Psychiatry Editorial Limiting and Repairing the Damage in Multiple Sclerosis , 2022 .

[9]  Y. Shimamoto,et al.  Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in rats , 1991, Journal of Neuroimmunology.

[10]  N. Larocca,et al.  High‐dose oral baclofen , 1991, Neurology.

[11]  R. Murray,et al.  The effect of high‐dose steroids on MRI gadolinium enhancement in acute demyelinating lesions , 1991, Neurology.

[12]  P. Scheltens,et al.  Quantitative MRI changes in gadolinium‐DTPA enhancement after high‐dose intravenous methylprednisolone in multiple sclerosis , 1991, Neurology.

[13]  S. Beer,et al.  [Steroid therapy in multiple sclerosis]. , 1991, Schweizerische medizinische Wochenschrift.

[14]  N. Patronas,et al.  Serial gadolinium‐enhanced magnetic resonance imaging scans in patients with early, relapsing‐remitting multiple sclerosis: Implications for clinical trials and natural history , 1991, Annals of neurology.

[15]  W. Mcdonald,et al.  Patterns of blood-brain barrier breakdown in inflammatory demyelination. , 1991, Brain : a journal of neurology.

[16]  M. Esiri,et al.  Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytological study. , 1991, Brain : a journal of neurology.

[17]  A. Cross,et al.  Adhesion molecules on endothelial cells in the central nervous system: an emerging area in the neuroimmunology of multiple sclerosis. , 1990, Clinical immunology and immunopathology.

[18]  B E Kendall,et al.  Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.

[19]  J. Kesselring.  [The pathogenesis of multiple sclerosis]. , 1990, Schweizerische medizinische Wochenschrift.

[20]  R. Sobel,et al.  Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. , 1990, The American journal of pathology.

[21]  C. Pozzilli,et al.  Serial study of gadolinium‐DTPA MRI enhancement in multiple sclerosis , 1990, Neurology.

[22]  D. N. Landon,et al.  Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. , 1990, Brain : a journal of neurology.

[23]  R. Poston,et al.  Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis , 1989, Journal of the Neurological Sciences.

[24]  J. Gybels,et al.  Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[25]  D. Li,et al.  The lesion of multiple sclerosis , 1989, Neurology.

[26]  L. Sternberger,et al.  Cell surface endothelial proteins altered in experimental allergic encephalomyelitis , 1989, Journal of Neuroimmunology.

[27]  B E Kendall,et al.  Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. , 1988, Brain : a journal of neurology.

[28]  G. Goldstein,et al.  Endothelial Cell‐Astrocyte Interactions , 1988, Annals of the New York Academy of Sciences.

[29]  W. Banks,et al.  Interactions between the blood-brain barrier and endogenous peptides: emerging clinical implications. , 1988, The American journal of the medical sciences.

[30]  J. Cervós-Navarro,et al.  Blood-brain barrier (BBB). Review from morphological aspect. , 1988, Histology and histopathology.

[31]  F. Jolesz,et al.  Neuroimaging and the lesion of multiple sclerosis. , 1987, AJNR. American journal of neuroradiology.

[32]  S. Ludwin,et al.  Blood-brain barrier permeability during Cuprizone-induced demyelination Implications for the pathogenesis of immune-mediated demyelinating diseases , 1987, Journal of the Neurological Sciences.

[33]  S. Atlas,et al.  Multiple sclerosis disease activity correlates with gadolinium‐enhanced magnetic resonance imaging , 1987, Annals of neurology.

[34]  S W Atlas,et al.  Multiple sclerosis: gadolinium enhancement in MR imaging. , 1986, Radiology.

[35]  A. Lefvert,et al.  IgG production within the central nervous system: A critical review of proposed formulae , 1985, Annals of neurology.

[36]  S. Cook,et al.  Effect of high–dose intravenous steriod administration on contrast‐enhancing computed tomographic scan lesions in multiple sclerosis , 1984 .

[37]  Bradbury Mw.  The structure and function of the blood-brain barrier. , 1984 .

[38]  W. J. Brown,et al.  The capillaries in acute and subacute multiple sclerosis plaques , 1978, Neurology.

[39]  W. Tourtellotte,et al.  Multiple sclerosis , 1978, Neurology.

[40]  T. Broman.  BLOOD‐BRAIN BARRIER DAMAGE IN MULTIPLE SCLEROSIS SUPRAVITAL TEST‐OBSERVATIONS , 1964, Acta neurologica Scandinavica. Supplementum.

[41]  R. Grossman,et al.  Meningeal enhancement in multiple sclerosis truth or coincidence? , 1992, AJNR. American journal of neuroradiology.

[42]  F. Barkhof,et al.  Meningeal Gd-DTPA enhancement in multiple sclerosis. , 1992, AJNR. American journal of neuroradiology.

[43]  J. Valk,et al.  Multiple Sclerosis, Neuromyelitis Optica, Concentric Sclerosis, and Schilder’s Diffuse Sclerosis , 1989 .

[44]  I. Allen,et al.  Abnormalities in the macroscopically normal white matter in cases of mild or spinal multiple sclerosis (MS). , 1981, Acta neuropathologica. Supplementum.

[45]  Luise Hertel.  Zur Pathogenese der multiplen Sklerose , 1938 .